Yixintang Pharmaceutical elects new board, approves governance rule changes

Yixintang Pharmaceutical Group held its Third Extraordinary General Meeting of Shareholders on November 13, 2025, with 57.8613% of the total voting shares represented. Shareholders approved the election of the Seventh Board of Directors and several revisions to governance documents.

Mr. Ruan Hongxian, Ms. Liu Qiong, Mr. Jiang Ning, Mr. Zhang Yong, and Ms. Ruan Aixiang were elected as non-independent directors. Mr. Ruan Hongxian received 99.4424% of the votes. Mr. Long Chao, Ms. Liu Lifang, and Mr. Shi Qian were elected as independent directors, with Mr. Long Chao receiving 99.6718% of the votes.

The company also announced the election of Ms. Guo Chunli as an employee representative director to the Seventh Board. Ms. Guo, holding 291,600 shares, will serve a three-year term commencing November 17, 2025. This ensures the board complies with regulations requiring that the number of directors who are also senior management or employee representatives does not exceed half of the total board members.

Additionally, shareholders approved revisions to the "Articles of Association," "Rules of Procedure for Shareholder Meetings," "Rules of Procedure for Board Meetings," and "Implementation Rules for Cumulative Voting System" with high percentages, ranging from 94.6364% to 99.9619% of votes in favor. The "Measures for the Administration of Raised Funds" also passed with 94.6742% approval.